{"entity":{"type":"insider","cik":"0001451038","url":"/insider/0001451038","json_url":"/insider/0001451038.json","name":"Lewis Tanya","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2020-11-04","last":"2023-06-15","span_basis":"filed_date"},"name_variants":[{"name":"Lewis Tanya","source":"filing","n_filings":5,"first_seen":"2020-11-04","last_seen":"2023-06-15"}],"transactions":[{"id":8253670,"accession":"0001104659-23-071774","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-071774","line_url":"/filing/0001104659-23-071774","is_derivative":false,"issuer_cik":"0001451038","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001451038","owner_cik":"0001451038","owner_name":"Lewis Tanya","owner_display_name":"Lewis Tanya","owner_url":"/insider/0001451038","role":"Officer (Chief Dev. Op. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. Op. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. Op. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12860.0,"shares_display":"12,860","price_per_share":24.058705287713842,"price_display":"24.06","price_state":"stated","total_value":309394.95,"total_display":"309,394.95","total_whole":"309,395","shares_owned_after":136110.0,"shares_owned_after_display":"136,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-15","scope":"insider","n_lines":2},{"id":7803812,"accession":"0001104659-23-062376","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-062376","line_url":"/filing/0001104659-23-062376#line-1","is_derivative":false,"issuer_cik":"0001451038","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001451038","owner_cik":"0001451038","owner_name":"Lewis Tanya","owner_display_name":"Lewis Tanya","owner_url":"/insider/0001451038","role":"Officer (Chief Dev. Op. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. Op. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. Op. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12207.0,"shares_display":"12,207","price_per_share":18.05,"price_display":"18.05","price_state":"stated","total_value":220336.35,"total_display":"220,336.35","total_whole":"220,336","shares_owned_after":148153.0,"shares_owned_after_display":"148,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider"},{"id":6124825,"accession":"0001104659-22-062608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-062608","line_url":"/filing/0001104659-22-062608#line-1","is_derivative":false,"issuer_cik":"0001451038","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001451038","owner_cik":"0001451038","owner_name":"Lewis Tanya","owner_display_name":"Lewis Tanya","owner_url":"/insider/0001451038","role":"Officer (Chief Dev. Op Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. Op Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. Op Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5473.0,"shares_display":"5,473","price_per_share":14.59,"price_display":"14.59","price_state":"stated","total_value":79851.07,"total_display":"79,851.07","total_whole":"79,851","shares_owned_after":120360.0,"shares_owned_after_display":"120,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-18","scope":"insider"},{"id":4612894,"accession":"0001209191-21-011496","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-011496","line_url":"/filing/0001209191-21-011496#line-1","is_derivative":false,"issuer_cik":"0001451038","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001451038","owner_cik":"0001451038","owner_name":"Lewis Tanya","owner_display_name":"Lewis Tanya","owner_url":"/insider/0001451038","role":"Officer (EVP, Chief Reg. Affairs)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Reg. Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2046.0,"shares_display":"2,046","price_per_share":15.5191,"price_display":"15.52","price_state":"stated","total_value":31752.0786,"total_display":"31,752.08","total_whole":"31,752","shares_owned_after":4143.0,"shares_owned_after_display":"4,143","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-17","scope":"insider"},{"id":3285007,"accession":"0001209191-20-057054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-057054","line_url":"/filing/0001209191-20-057054#line-2","is_derivative":false,"issuer_cik":"0001451038","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001451038","owner_cik":"0001451038","owner_name":"Lewis Tanya","owner_display_name":"Lewis Tanya","owner_url":"/insider/0001451038","role":"Officer (EVP,Chief Reg.&Quality Officer)","role_mark":"O","role_mark_label":"Officer (EVP,Chief Reg.&Quality Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP,Chief Reg.&Quality Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":226.0,"shares_display":"226","price_per_share":15.58,"price_display":"15.58","price_state":"stated","total_value":3521.08,"total_display":"3,521.08","total_whole":"3,521","shares_owned_after":539.0,"shares_owned_after_display":"539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-30","filed_date":"2020-11-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001737953","name":"Replimune Group, Inc.","url":"/issuer/0001737953","role":"Officer (Chief Dev. Op. Officer)","n_filings":3,"first_seen":"2022-05-18","last_seen":"2023-06-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001503802","name":"Karyopharm Therapeutics Inc.","url":"/issuer/0001503802","role":"Officer (EVP, Chief Reg. Affairs)","n_filings":2,"first_seen":"2020-11-04","last_seen":"2021-02-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001451038","retrieved_at":"2026-08-23T14:09:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}